We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
Last close (HKD)79.35−1.30 (−1.61%)as of 3 Nov 2026
Funds that hold it3One fund per scheme
Held through a master fund30 buy the stock themselves
Largest weight in a single fund8.62%Of that fund's NAV
Median weight4.88%Half the funds hold more than this
Which funds let you invest in 1801.HK
Sorted by weight held, largest first
Investors in Thailand can buy 1801.HK through 3 mutual funds open to retail investors. Most of them (3 funds) don't buy the stock themselves. Instead they invest in a master fund abroad, which in turn holds 1801.HK.
Via several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index)
−13.51%
1801.HK share price
0.00%
Price change over the selected periodN/A
50-day average
200-day average
Thai funds holding 1801.HK
3 funds · Highest 8.62% · Median 4.88%
How the weights are spread
Number of funds by weight range
0
0
2
0
1
0
< 1%1–3%3–5%5–8%8–12%12%+
The many funds holding less than 3% are usually index funds holding at market weight · Funds holding more than 8% have deliberately chosen a large position
How many funds each AMC holds it through
UOBAM
How Thai money reaches 1801.HK
3 master funds
Master fund
Thai funds using this route
Master fund's 1801.HK weight
several master funds (Global X China Biotech, Kraneshares MSCI All China Health Care Index)
1
8.62%
Hang Seng Biotech Index ETF
1
4.88%
several master funds
1
3.24%
Data sourcesFunds that buy the stock themselves: top 5 holdings from the AMC's fact sheet as of 30 Sep 2026 · Funds that invest through a master fund: the master fund's portfolio from its issuer's fact sheet or prospectus · Each scheme counts as one fund · Share price: Market data · Weights are as of the report date, and funds can change their portfolios at any time · Investing involves risk. This is not investment advice.
Showing 3 of 3 funds you can buy · The full list is in the Expert view · Latest weights from portfolio reports, and funds can change their portfolios at any time · Past performance is not a guarantee of future performance
Technical analysis
Closed at 79.35 HKD on 3 Nov 2026
Daily trendClear downtrendScore −1.00 on a scale of −1 to +1 · 1228 bars
RSI(14)
30.8
ADX(14)
34.8
Position in the price range
0%
Weekly trendClear downtrendScore −0.60 on a scale of −1 to +1 · 262 bars
RSI(14)
40.2
ADX(14)
18.6
Position in the price range
17%
Monthly trendLeaning upScore 0.33 on a scale of −1 to +1 · 61 bars
RSI(14)
51.7
ADX(14)
28.0
Position in the price range
62%
Moving averages (daily)
Period
SMA
EMA
Price vs line
10 days
81.99
82.37
Below
20 days
86.92
85.91
Below
50 days
94.67
90.49
Below
100 days
91.22
90.73
Below
200 days
Indicators (daily)
Indicator
Value
Signal
RSI(14)
30.75
Down
MACD(12,26)
−4.35
Down
ADX(14)
34.75
Neutral
ATR(14) % of price
2.11
Neutral
Support and resistance (weekly pivots)
s375
s277
s1
Trend score = average of the moving-average group and the indicator group ((up signals − down signals) ÷ number of signals) · RSI and ATR use Wilder's method · MACD uses the 12- and 26-period EMA · An ADX of 25 or above counts as a clear trend · Calculated from daily closing prices from Market data · Not investment advice
No financial statements for 1801.HK in the system yet — the share price above is the actual daily close
One fund counted per scheme · Funds investing through a master fund show the master fund's weight in 1801.HK, not the look-through weight · Past performance is not a guarantee of future performance
UCHIUnited China Healthcare Innovation Fund
TCHSTRATEGYTISCO China Strategy Fund